Real-World Outcomes of Patients With Malignant Pleural Mesothelioma Receiving a Combination of Ipilimumab and Nivolumab as First- or Later-Line Treatment

Autor: Schmid, Sabine, Holer, Lisa, Gysel, Katrin, Koster, Kira-Lee, Rothschild, Sacha I., Boos, Laura A., Frehner, Lorenz, Cardoso Almeida, Sabine, Britschgi, Christian, Metaxas, Yannis, Mark, Michael, Froesch, Patrizia, Janthur, Wolf-Dieter, Allemann, Anna, Waibel, Christine, Von der Mühll-Schill, Catherine, Früh, Martin, Mauti, Laetitia A.
Zdroj: In JTO Clinical and Research Reports December 2024 5(12)
Databáze: ScienceDirect